| Contributors |
|
xv | |
| Reviewers |
|
xvii | |
| Preface |
|
xix | |
| Section I. The Essentials |
|
1 | (210) |
|
1 Assessment of Progressive Care Patients and Their Families |
|
|
3 | (16) |
|
|
|
|
|
3 | (2) |
|
|
|
4 | (1) |
|
|
|
4 | (1) |
|
Comprehensive Initial Assessment |
|
|
4 | (1) |
|
|
|
4 | (1) |
|
Patient Safety Considerations in Admission Assessments |
|
|
4 | (1) |
|
Prearrival Assessment: Before the Action Begins |
|
|
5 | (1) |
|
Admission Quick Check Assessment |
|
|
5 | (3) |
|
|
|
6 | (1) |
|
Circulation and Cerebral Perfusion |
|
|
7 | (1) |
|
|
|
7 | (1) |
|
Drugs and Diagnostic Tests |
|
|
7 | (1) |
|
|
|
8 | (1) |
|
Comprehensive Initial Assessment |
|
|
8 | (7) |
|
|
|
8 | (1) |
|
|
|
9 | (1) |
|
Physical Assessment by Body System |
|
|
10 | (5) |
|
Transition/Discharge Planning |
|
|
15 | (1) |
|
|
|
15 | (1) |
|
|
|
16 | (1) |
|
|
|
16 | (4) |
|
Progressive Care Assessment |
|
|
16 | (1) |
|
|
|
17 | (2) |
|
2 Planning Care for Progressive Care Patients and Their Families |
|
|
19 | (18) |
|
|
|
Interprofessional Plan of Care |
|
|
20 | (1) |
|
Planning Care Through Staffing Considerations |
|
|
20 | (1) |
|
Patient Safety Considerations in Planning Care |
|
|
21 | (1) |
|
Prevention of Common Complications |
|
|
22 | (5) |
|
|
|
22 | (1) |
|
|
|
22 | (1) |
|
Hospital-Acquired Infections |
|
|
22 | (2) |
|
|
|
24 | (1) |
|
Sleep Pattern Disturbance |
|
|
24 | (1) |
|
|
|
25 | (1) |
|
|
|
25 | (2) |
|
Patient and Family Education |
|
|
27 | (1) |
|
Assessment of Learning Readiness |
|
|
27 | (1) |
|
Strategies to Address Patient and Family Education |
|
|
27 | (1) |
|
|
|
28 | (1) |
|
|
|
28 | (2) |
|
Transporting the Progressive Care Patient |
|
|
30 | (4) |
|
Assessment of Risk for Complications |
|
|
30 | (1) |
|
Level of Care Required During Transport |
|
|
31 | (1) |
|
|
|
32 | (1) |
|
|
|
33 | (1) |
|
|
|
33 | (1) |
|
Transitioning to the Next Stage of Care |
|
|
34 | (1) |
|
Supporting Patients and Their Families During the Dying Process |
|
|
34 | (1) |
|
|
|
34 | (1) |
|
|
|
34 | (3) |
|
|
|
34 | (1) |
|
|
|
35 | (1) |
|
Patient and Family Education |
|
|
35 | (1) |
|
|
|
35 | (1) |
|
|
|
35 | (1) |
|
Transport of Critically Ill Patients |
|
|
35 | (1) |
|
|
|
35 | (2) |
|
3 Interpretation and Management of Basic Cardiac Rhythms |
|
|
37 | (34) |
|
|
|
|
|
37 | (1) |
|
ECG Waveforms, Complexes, and Intervals |
|
|
38 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
Basic Electrocardiography |
|
|
39 | (1) |
|
|
|
40 | (1) |
|
Determination of the Heart Rate |
|
|
41 | (2) |
|
Determination of Cardiac Rhythm |
|
|
43 | (1) |
|
|
|
43 | (1) |
|
Rhythms Originating in the Sinus Node |
|
|
43 | (2) |
|
|
|
43 | (1) |
|
|
|
43 | (1) |
|
|
|
44 | (1) |
|
|
|
44 | (1) |
|
|
|
45 | (1) |
|
Dysrhythmias Originating in the Atria |
|
|
45 | (10) |
|
Premature Atrial Complexes |
|
|
45 | (1) |
|
Wandering Atrial Pacemaker and Multifocal Atrial Tachycardia |
|
|
46 | (1) |
|
|
|
47 | (1) |
|
|
|
47 | (3) |
|
|
|
50 | (4) |
|
Supraventricular Tachycardia (SVT) |
|
|
54 | (1) |
|
Dysrhythmias Originating in the Atrioventricular Junction |
|
|
55 | (1) |
|
Premature Junctional Complexes |
|
|
55 | (1) |
|
Junctional Rhythm, Accelerated Junctional Rhythm, and Junctional Tachycardia |
|
|
56 | (1) |
|
Dysrhythmias Originating in the Ventricles |
|
|
56 | (4) |
|
Premature Ventricular Complexes |
|
|
56 | (1) |
|
Idioventricular Rhythm and Accelerated Idioventricular Rhythm (AIVR) |
|
|
57 | (1) |
|
|
|
58 | (1) |
|
|
|
58 | (2) |
|
|
|
60 | (1) |
|
|
|
60 | (3) |
|
First-Degree Atrioventricular Block |
|
|
60 | (1) |
|
Second-Degree Atrioventricular Block |
|
|
61 | (1) |
|
High-Grade Atrioventricular Block |
|
|
62 | (1) |
|
Third-Degree Atrioventricular Block (Complete Block) |
|
|
62 | (1) |
|
|
|
63 | (5) |
|
|
|
63 | (1) |
|
|
|
63 | (1) |
|
|
|
63 | (1) |
|
Components of a Pacing System |
|
|
64 | (1) |
|
Basics of Pacemaker Operation |
|
|
64 | (2) |
|
Initiating Transvenous Ventricular Pacing |
|
|
66 | (1) |
|
Initiating Epicardial Pacing |
|
|
66 | (1) |
|
External (Transcutaneous) Pacemakers |
|
|
67 | (1) |
|
Defibrillation and Cardioversion |
|
|
68 | (1) |
|
|
|
68 | (1) |
|
Automatic External Defibrillators |
|
|
68 | (1) |
|
|
|
69 | (1) |
|
|
|
69 | (2) |
|
|
|
70 | (1) |
|
|
|
71 | (28) |
|
|
|
|
|
71 | (8) |
|
|
|
71 | (2) |
|
Components of Cardiac Output/Cardiac Index |
|
|
73 | (1) |
|
Stroke Volume and Stroke Volume Index |
|
|
74 | (1) |
|
|
|
74 | (1) |
|
Factors Affecting Stroke Volume/Stroke Volume Index |
|
|
74 | (5) |
|
Basic Components of Hemodynamic Monitoring Systems |
|
|
79 | (2) |
|
Pulmonary Artery Catheter |
|
|
79 | (1) |
|
|
|
79 | (1) |
|
|
|
79 | (1) |
|
|
|
79 | (1) |
|
|
|
79 | (1) |
|
Pressure Bag and Flush Device |
|
|
80 | (1) |
|
|
|
81 | (1) |
|
Obtaining Accurate CVP and Arterial Values |
|
|
81 | (3) |
|
|
|
81 | (1) |
|
Leveling the Transducer to the Catheter Tip |
|
|
81 | (1) |
|
Ensuring Accurate Waveform Transmission |
|
|
82 | (2) |
|
Insertion and Removal of Catheters |
|
|
84 | (2) |
|
|
|
84 | (1) |
|
|
|
84 | (2) |
|
Obtaining and Interpreting Hemodynamic Waveforms |
|
|
86 | (6) |
|
|
|
86 | (1) |
|
|
|
87 | (3) |
|
Artifacts in Hemodynamic Waveforms: Respiratory Influence |
|
|
90 | (2) |
|
Continuous Mixed and Central Venous Oxygen Monitoring (Svo2/Scvo2) |
|
|
92 | (1) |
|
Svo2/Scvo2 Monitoring Principles |
|
|
92 | (1) |
|
Minimally Invasive Hemodynamic Monitoring |
|
|
92 | (2) |
|
Thoracic Bioimpedance/Bioreactance |
|
|
92 | (1) |
|
Pulse Contour Measurement |
|
|
93 | (1) |
|
Ambulatory Pulmonary Artery Pressure Monitoring |
|
|
93 | (1) |
|
|
|
94 | (5) |
|
|
|
94 | (1) |
|
Minimally Invasive Hemodynamic Monitoring |
|
|
95 | (1) |
|
|
|
96 | (2) |
|
Evidence-Based Practice Guidelines |
|
|
98 | (1) |
|
5 Airway and Ventilatory Management |
|
|
99 | (42) |
|
|
|
|
|
Diagnostic Tests, Monitoring Systems, and Respiratory Assessment Techniques |
|
|
99 | (9) |
|
Arterial Blood Gas Monitoring |
|
|
99 | (5) |
|
Venous Blood Gas Monitoring |
|
|
104 | (1) |
|
|
|
104 | (2) |
|
Assessing Pulmonary Function |
|
|
106 | (2) |
|
|
|
108 | (5) |
|
|
|
108 | (1) |
|
|
|
108 | (1) |
|
|
|
108 | (1) |
|
Esophageal Tracheal Airway |
|
|
109 | (1) |
|
|
|
109 | (3) |
|
|
|
112 | (1) |
|
|
|
113 | (1) |
|
|
|
113 | (4) |
|
|
|
113 | (1) |
|
|
|
114 | (3) |
|
Basic Ventilatory Management |
|
|
117 | (18) |
|
|
|
117 | (1) |
|
|
|
117 | (1) |
|
Patient-Ventilator System |
|
|
118 | (2) |
|
|
|
120 | (2) |
|
Complications of Mechanical Ventilation |
|
|
122 | (2) |
|
Weaning From Short-Term Mechanical Ventilation |
|
|
124 | (3) |
|
Weaning From Long-Term Mechanical Ventilation |
|
|
127 | (2) |
|
Respiratory Fatigue, Rest, and Conditioning |
|
|
129 | (1) |
|
|
|
130 | (1) |
|
|
|
130 | (1) |
|
|
|
131 | (1) |
|
Systematic Institutional Initiatives for the Management of the LTMV Patient Population |
|
|
131 | (1) |
|
Troubleshooting Ventilators |
|
|
131 | (1) |
|
|
|
132 | (1) |
|
|
|
132 | (3) |
|
|
|
135 | (1) |
|
Maximizing Oxygenation, Ventilation, and Patient-Ventilator Synchrony |
|
|
135 | (1) |
|
|
|
135 | (1) |
|
Monitor Oxygenation and Ventilation Status Frequently |
|
|
135 | (1) |
|
Physiotherapy and Monitoring |
|
|
136 | (1) |
|
Maintain Oxygenation and Ventilatory Support at All Times |
|
|
136 | (1) |
|
Weaning From Mechanical Ventilation |
|
|
136 | (1) |
|
|
|
136 | (1) |
|
|
|
136 | (1) |
|
Reducing Anxiety and Providing Psychosocial Support |
|
|
136 | (1) |
|
|
|
136 | (5) |
|
|
|
136 | (1) |
|
|
|
137 | (1) |
|
Weaning From Mechanical Ventilation |
|
|
138 | (1) |
|
|
|
138 | (1) |
|
|
|
138 | (3) |
|
6 Pain and Sedation Management |
|
|
141 | (20) |
|
|
|
|
|
Physiologic Mechanisms of Pain |
|
|
141 | (2) |
|
|
|
141 | (1) |
|
|
|
142 | (1) |
|
|
|
142 | (1) |
|
|
|
143 | (1) |
|
|
|
144 | (1) |
|
A Multimodal Approach to Pain Management |
|
|
144 | (2) |
|
Nonsteroidal Anti-Inflammatory Drugs |
|
|
146 | (1) |
|
|
|
146 | (1) |
|
|
|
147 | (3) |
|
|
|
147 | (1) |
|
|
|
148 | (1) |
|
Patient-Controlled Analgesia |
|
|
148 | (1) |
|
Switching From IV to Oral Opioid Analgesia |
|
|
149 | (1) |
|
|
|
150 | (2) |
|
|
|
151 | (1) |
|
Epidural Local Anesthetics |
|
|
151 | (1) |
|
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
153 | (1) |
|
Deep Breathing and Progressive Relaxation |
|
|
153 | (1) |
|
|
|
154 | (1) |
|
Special Considerations for Pain Management in Older Adults |
|
|
154 | (1) |
|
|
|
154 | (1) |
|
|
|
154 | (1) |
|
Principles of Pain Management |
|
|
154 | (1) |
|
|
|
154 | (5) |
|
|
|
155 | (1) |
|
|
|
156 | (1) |
|
|
|
156 | (1) |
|
Goals of Sedation, Monitoring, and Management |
|
|
157 | (1) |
|
Principles of Management for the Use of Sedatives |
|
|
158 | (1) |
|
|
|
159 | (2) |
|
|
|
159 | (1) |
|
|
|
160 | (1) |
|
Evidence-Based Practice Guidelines |
|
|
160 | (1) |
|
|
|
161 | (30) |
|
|
|
|
|
161 | (1) |
|
Medication Administration Methods |
|
|
162 | (1) |
|
|
|
162 | (1) |
|
Intramuscular or Subcutaneous |
|
|
162 | (1) |
|
|
|
162 | (1) |
|
|
|
163 | (1) |
|
|
|
163 | (1) |
|
|
|
163 | (1) |
|
Central Nervous System Pharmacology |
|
|
163 | (8) |
|
|
|
163 | (4) |
|
|
|
167 | (1) |
|
|
|
168 | (3) |
|
Cardiovascular System Pharmacology |
|
|
171 | (7) |
|
|
|
171 | (1) |
|
|
|
171 | (3) |
|
|
|
174 | (2) |
|
Vasodilators and Remodeling Agents |
|
|
176 | (1) |
|
Soluble Guanylate Cyclase Stimulators |
|
|
177 | (1) |
|
|
|
177 | (1) |
|
|
|
178 | (1) |
|
|
|
178 | (2) |
|
|
|
179 | (1) |
|
|
|
179 | (1) |
|
|
|
180 | (1) |
|
|
|
180 | (1) |
|
|
|
180 | (1) |
|
|
|
180 | (1) |
|
Gastrointestinal Pharmacology |
|
|
180 | (2) |
|
|
|
180 | (1) |
|
Acute Peptic Ulcer Bleeding |
|
|
181 | (1) |
|
|
|
181 | (1) |
|
|
|
182 | (1) |
|
|
|
182 | (1) |
|
|
|
183 | (4) |
|
|
|
183 | (2) |
|
|
|
185 | (1) |
|
Direct Thrombin Inhibitors |
|
|
185 | (1) |
|
Glycoprotein IIb/IIIa Inhibitor |
|
|
186 | (1) |
|
|
|
186 | (1) |
|
|
|
187 | (1) |
|
|
|
187 | (1) |
|
|
|
187 | (1) |
|
|
|
188 | (1) |
|
|
|
188 | (1) |
|
Special Dosing Considerations |
|
|
188 | (2) |
|
Drug Disposition in Older adults |
|
|
188 | (1) |
|
Therapeutic Drug Monitoring |
|
|
189 | (1) |
|
|
|
190 | (1) |
|
|
|
190 | (1) |
|
Evidence-Based Practice Guidelines |
|
|
190 | (1) |
|
8 Ethical and Legal Considerations |
|
|
191 | (20) |
|
|
|
Types of Ethical Problems |
|
|
191 | (2) |
|
The Foundation for Ethical Decision Making |
|
|
193 | (5) |
|
Professional Codes and Standards |
|
|
193 | (1) |
|
|
|
193 | (1) |
|
Leg,a1Standards 194I Principles of Ethics |
|
|
194 | (2) |
|
|
|
196 | (1) |
|
Frameworks for Ethical Analysis |
|
|
196 | (1) |
|
|
|
197 | (1) |
|
|
|
198 | (1) |
|
The Process of Ethical Analysis |
|
|
198 | (2) |
|
|
|
199 | (1) |
|
|
|
199 | (1) |
|
|
|
199 | (1) |
|
|
|
199 | (1) |
|
Contemporary Ethical Issues |
|
|
200 | (7) |
|
|
|
200 | (2) |
|
|
|
202 | (3) |
|
|
|
205 | (2) |
|
Building an Ethical Environment |
|
|
207 | (2) |
|
|
|
209 | (4) |
|
Professional Codes, Standards, and Position Statements |
|
|
210 | (1) |
|
Evidence-Based Guidelines |
|
|
210 | (1) |
|
Online References of Interest: Related to Legal and Ethical Considerations |
|
|
210 | (1) |
| Section II. Pathologic Conditions |
|
211 | (212) |
|
|
|
213 | (32) |
|
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
213 | (4) |
|
|
|
213 | (1) |
|
|
|
213 | (3) |
|
Percutaneous Coronary Interventions |
|
|
216 | (1) |
|
Other Percutaneous Coronary Interventions |
|
|
217 | (1) |
|
|
|
217 | (25) |
|
Acute Ischemic Heart Disease |
|
|
217 | (6) |
|
Principles of Management of Acute Ischemic Heart Disease |
|
|
223 | (4) |
|
Electrophysiology Studies |
|
|
227 | (8) |
|
|
|
235 | (4) |
|
|
|
239 | (3) |
|
|
|
242 | (3) |
|
|
|
242 | (1) |
|
Coronary Revascularization |
|
|
242 | (1) |
|
Acute Ischemic Heart Disease |
|
|
242 | (1) |
|
|
|
242 | (1) |
|
|
|
242 | (1) |
|
Evidence-Based Practice Guidelines |
|
|
243 | (2) |
|
|
|
245 | (32) |
|
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
245 | (7) |
|
|
|
245 | (5) |
|
Computed Tomography, Magnetic Resonance Imaging, and Bedside Ultrasonography |
|
|
250 | (1) |
|
|
|
250 | (1) |
|
|
|
251 | (1) |
|
Thoracic Surgery and Procedures |
|
|
252 | (1) |
|
Principles of Management for Thoracic Surgery and Procedures |
|
|
253 | (1) |
|
|
|
253 | (21) |
|
Acute Respiratory Failure |
|
|
253 | (4) |
|
Acute Respiratory Distress Syndrome |
|
|
257 | (1) |
|
Acute Respiratory Failure in the Patient With Chronic Obstructive Pulmonary Disease (also called COPD Exacerbation) |
|
|
258 | (4) |
|
Acute Respiratory Failure in the Patient With Asthma (also called acute severe asthma) |
|
|
262 | (2) |
|
Principles of Management for Asthma Exacerbations |
|
|
264 | (1) |
|
Interstitial Lung Disease |
|
|
264 | (1) |
|
Pulmonary Arterial Hypertension |
|
|
265 | (2) |
|
|
|
267 | (3) |
|
|
|
270 | (4) |
|
|
|
274 | (3) |
|
Critical Care Management of Respiratory Problems |
|
|
274 | (1) |
|
Chest X-Ray Interpretation |
|
|
274 | (1) |
|
Evidence-Based Practice Resources |
|
|
274 | (3) |
|
|
|
277 | (20) |
|
|
|
|
|
277 | (7) |
|
Etiology, Risk Factors, and Pathogenesis |
|
|
278 | (1) |
|
|
|
279 | (2) |
|
Principles of Management of Sepsis and Septic Shock |
|
|
281 | (3) |
|
|
|
284 | (5) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
284 | (3) |
|
Principles of Management for Overdose |
|
|
287 | (2) |
|
|
|
289 | (3) |
|
|
|
289 | (2) |
|
Principles of Management of Pressure Injury |
|
|
291 | (1) |
|
Healthcare-Associated Infections |
|
|
292 | (2) |
|
Selected Infectious Diseases |
|
|
293 | (1) |
|
|
|
294 | (3) |
|
|
|
294 | (1) |
|
|
|
294 | (1) |
|
|
|
295 | (1) |
|
Healthcare-Associated Infections |
|
|
295 | (1) |
|
Selected Infectious Diseases |
|
|
295 | (2) |
|
|
|
297 | (26) |
|
|
|
|
|
Special Assessment Techniques and Diagnostic Tests |
|
|
297 | (8) |
|
|
|
297 | (1) |
|
Glasgow Coma Scale (GCS) and the Full Outline of Unresponsiveness (FOUR) Score |
|
|
298 | (2) |
|
|
|
300 | (1) |
|
|
|
300 | (1) |
|
|
|
301 | (1) |
|
Cranial Nerve Assessment and Assessment of Brain Stem Function |
|
|
302 | (1) |
|
Vital Sign Alterations in Neurologic Dysfunction |
|
|
303 | (2) |
|
|
|
305 | (2) |
|
|
|
305 | (1) |
|
Magnetic Resonance Imaging |
|
|
305 | (1) |
|
|
|
306 | (1) |
|
Cerebral (Catheter) Angiography |
|
|
306 | (1) |
|
Transcranial Doppler Ultrasound |
|
|
307 | (1) |
|
|
|
307 | (1) |
|
Electromyography/Nerve Conduction Studies |
|
|
307 | (1) |
|
|
|
307 | (4) |
|
Causes of Increased Intracranial Pressure |
|
|
308 | (1) |
|
|
|
308 | (2) |
|
|
|
310 | (1) |
|
Principles of Management of Increased ICP |
|
|
310 | (1) |
|
|
|
311 | (4) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
311 | (1) |
|
|
|
312 | (1) |
|
|
|
313 | (1) |
|
Principles of Management of Acute Ischemic Stroke |
|
|
313 | (2) |
|
|
|
315 | (1) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
315 | (1) |
|
|
|
315 | (1) |
|
|
|
315 | (1) |
|
Principles of Management of Intracerebral Hemorrhage |
|
|
315 | (1) |
|
|
|
316 | (2) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
3161 | |
|
|
|
316 | (1) |
|
|
|
317 | (1) |
|
Principles of Management of Seizures |
|
|
317 | (1) |
|
Infections of the Central Nervous System |
|
|
318 | (1) |
|
|
|
318 | (1) |
|
|
|
318 | (1) |
|
|
|
318 | (1) |
|
|
|
318 | (1) |
|
|
|
319 | (1) |
|
|
|
319 | (1) |
|
|
|
319 | (1) |
|
Amyotrophic Lateral Sclerosis |
|
|
319 | (1) |
|
|
|
319 | (4) |
|
Assessment and Diagnostic Testing |
|
|
319 | (1) |
|
|
|
320 | (1) |
|
Acute Ischemic Stroke and Hemorrhagic Stroke |
|
|
320 | (1) |
|
|
|
320 | (1) |
|
Infections of the Central Nervous System |
|
|
320 | (1) |
|
|
|
320 | (1) |
|
|
|
320 | (3) |
|
13 Hematologic and Immune Systems |
|
|
323 | (16) |
|
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
323 | (3) |
|
|
|
323 | (1) |
|
|
|
323 | (1) |
|
|
|
324 | (1) |
|
|
|
324 | (1) |
|
|
|
324 | (1) |
|
Total White Blood Cell Count |
|
|
325 | (1) |
|
White Blood Cell Differential |
|
|
325 | (1) |
|
|
|
325 | (1) |
|
|
|
325 | (1) |
|
Additional Tests and Procedures |
|
|
326 | (1) |
|
|
|
326 | (10) |
|
|
|
326 | (2) |
|
|
|
328 | (3) |
|
|
|
331 | (5) |
|
|
|
336 | (3) |
|
|
|
336 | (1) |
|
Immunocompromised Patient |
|
|
336 | (1) |
|
|
|
336 | (3) |
|
14 Gastrointestinal System |
|
|
339 | (32) |
|
|
|
|
|
339 | (23) |
|
Acute Gastrointestinal Bleeding |
|
|
339 | (10) |
|
|
|
349 | (4) |
|
|
|
353 | (3) |
|
|
|
356 | (2) |
|
|
|
358 | (2) |
|
Bariatric (Weight Reduction) Surgery |
|
|
360 | (1) |
|
|
|
360 | (2) |
|
Nutritional Support for Acutely Ill Patients |
|
|
362 | (5) |
|
|
|
362 | (1) |
|
Nutritional Case: Special Populations |
|
|
362 | (1) |
|
|
|
362 | (5) |
|
|
|
367 | (4) |
|
|
|
367 | (1) |
|
|
|
367 | (1) |
|
|
|
368 | (1) |
|
Intestinal Ischemia/Bowel Obstruction |
|
|
368 | (1) |
|
|
|
368 | (1) |
|
Online References of Interest |
|
|
368 | (1) |
|
Bariatric (Gastric Bypass) Surgery |
|
|
369 | (2) |
|
|
|
371 | (16) |
|
|
|
|
|
371 | (5) |
|
|
|
374 | (1) |
|
Principles of Management of Acute Kidney Injury |
|
|
374 | (2) |
|
|
|
376 | (6) |
|
Calcium Imbalance: Hypocalcemia |
|
|
378 | (2) |
|
Principles of Management for Electrolyte Imbalances |
|
|
380 | (2) |
|
Renal Replacement Therapy |
|
|
382 | (4) |
|
|
|
382 | (1) |
|
Dialyzer/Hemofilters/Dialysate |
|
|
383 | (1) |
|
|
|
383 | (1) |
|
Indications for and Efficacy of Renal Replacement Therapy Modes |
|
|
384 | (2) |
|
General Renal Replacement Therapy Interventions |
|
|
386 | (1) |
|
|
|
386 | (1) |
|
|
|
386 | (1) |
|
General Renal and Electrolyte |
|
|
386 | (1) |
|
|
|
386 | (1) |
|
Renal Replacement Therapy |
|
|
386 | (1) |
|
|
|
386 | (1) |
|
|
|
387 | (20) |
|
|
|
|
|
387 | (1) |
|
|
|
387 | (10) |
|
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar |
|
|
387 | (7) |
|
|
|
394 | (3) |
|
Summary: Hyperglycemia and Hypoglycemia |
|
|
397 | (1) |
|
Pituitary Gland Function and Associated Disorders |
|
|
397 | (4) |
|
Syndrome of Inappropriate Antidiuretic Hormone Secretion |
|
|
398 | (1) |
|
|
|
399 | (2) |
|
Summary: Pituitary Gland and DI/SIADH |
|
|
401 | (1) |
|
Thyroid Gland Function and Associated Disorders |
|
|
401 | (2) |
|
Hyperthyroidism and Thyroid Storm |
|
|
402 | (1) |
|
Hypothyroidism and Myxedema Coma |
|
|
402 | (1) |
|
Summary: Hyperthyroidism and Thyroid Storm, Hypothyroidism and Myxedema Coma |
|
|
403 | (1) |
|
Adrenal Gland Function and Associated Disorders |
|
|
403 | (2) |
|
|
|
403 | (1) |
|
|
|
403 | (1) |
|
Addison Disease and Crisis |
|
|
404 | (3637) |
|
Critical Illness- Related Corticosteroid Insufficiency |
|
|
4041 | |
|
Pheochromocytoma and Catecholamine Crisis |
|
|
404 | (1) |
|
Summary: Adrenal Gland Dysfunction |
|
|
405 | (1) |
|
|
|
405 | (2) |
|
|
|
405 | (1) |
|
Hyperglycemia, DKA, and HHS |
|
|
405 | (1) |
|
SIADH and Diabetes Insipidus |
|
|
405 | (1) |
|
Hyperthyroidism and Thyroid Storm |
|
|
405 | (1) |
|
Hypothyroidism and Myxedema Coma |
|
|
405 | (1) |
|
Adrenal Gland, Cushing Disease, and Pheochromocytoma |
|
|
405 | (1) |
|
Critical Illness-Related Corticosteroid Insufficiency |
|
|
406 | (1) |
|
|
|
407 | (16) |
|
|
|
|
|
|
|
407 | (5) |
|
Primary, Secondary, and Tertiary Trauma Surveys |
|
|
408 | (1) |
|
|
|
408 | (2) |
|
|
|
410 | (1) |
|
Physiologic Consequences of Trauma |
|
|
411 | (1) |
|
Common Injuries in the Trauma Patient |
|
|
412 | (6) |
|
|
|
412 | (4) |
|
|
|
416 | (1) |
|
|
|
417 | (1) |
|
Complications of Traumatic Injury in Severe Multisystem Trauma |
|
|
418 | (3) |
|
|
|
418 | (2) |
|
Infection, Systemic Inflammatory Response Syndrome, Sepsis/Septic Shock, and Multiple Organ Dysfunction |
|
|
420 | (1) |
|
Acute Respiratory Distress Syndrome |
|
|
421 | (1) |
|
Psychological Consequences of Trauma |
|
|
421 | (1) |
|
|
|
422 | (3) |
|
|
|
422 | (1) |
| Section III. Advanced Concepts |
|
423 | (94) |
|
|
|
425 | (42) |
|
|
|
The 12-Lead Electrocardiogram |
|
|
425 | (20) |
|
|
|
429 | (2) |
|
|
|
431 | (3) |
|
|
|
434 | (6) |
|
|
|
440 | (5) |
|
Advanced Dysrhythmia Interpretation |
|
|
445 | (9) |
|
Supraventricular Tachycardias |
|
|
445 | (3) |
|
Polymorphic Ventricular Tachycardias |
|
|
448 | (1) |
|
Differentiating Wide QRS Beats and Rhythms |
|
|
449 | (5) |
|
|
|
454 | (2) |
|
|
|
454 | (1) |
|
Choosing the Best Leads for ST-Segment Monitoring |
|
|
455 | (1) |
|
|
|
456 | (8) |
|
Evaluating Pacemaker Function |
|
|
457 | (1) |
|
|
|
457 | (3) |
|
|
|
460 | (4) |
|
|
|
464 | (3) |
|
|
|
464 | (1) |
|
|
|
464 | (1) |
|
Long QT Syndrome and Brugada Syndrome |
|
|
464 | (1) |
|
|
|
464 | (1) |
|
|
|
465 | (1) |
|
|
|
465 | (2) |
|
19 Advanced Cardiovascular Concepts |
|
|
467 | (28) |
|
|
|
|
|
467 | (25) |
|
|
|
467 | (5) |
|
|
|
472 | (6) |
|
|
|
478 | (2) |
|
|
|
480 | (4) |
|
|
|
484 | (5) |
|
Ventricular Assist Devices |
|
|
489 | (3) |
|
|
|
492 | (3) |
|
|
|
492 | (1) |
|
|
|
493 | (1) |
|
|
|
493 | (1) |
|
|
|
493 | (1) |
|
|
|
493 | (1) |
|
Thoraco-Abdominal Aneurysms |
|
|
493 | (1) |
|
Ventricular Assist Devices |
|
|
493 | (1) |
|
|
|
494 | (1) |
|
Evidence-Based Practice/Guidelines |
|
|
494 | (1) |
|
20 Advanced Neurologic Concepts |
|
|
495 | (22) |
|
|
|
|
|
|
|
495 | (4) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
495 | (1) |
|
|
|
495 | (1) |
|
|
|
496 | (1) |
|
Principles of Management of Aneurysmal Subarachnoid Hemorrhage |
|
|
497 | (2) |
|
|
|
499 | (6) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
499 | (3) |
|
|
|
502 | (1) |
|
|
|
503 | (1) |
|
Principles of Management of Traumatic Brain Injury |
|
|
503 | (2) |
|
Traumatic Spinal Cord Injury |
|
|
505 | (5) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
505 | (1) |
|
|
|
505 | (3) |
|
|
|
508 | (1) |
|
Principles of Management of Acute Spinal Cord Injury |
|
|
508 | (2) |
|
Future Spinal Cord Injury Treatment |
|
|
510 | (1) |
|
|
|
510 | (3) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
510 | (1) |
|
|
|
511 | (1) |
|
|
|
511 | (1) |
|
Principles of Management of Intracranial Tumors |
|
|
512 | (1) |
|
Special Considerations: Transsphenoidal Resection of Pituitary Tumors |
|
|
513 | (1) |
|
Special Procedures: Invasive Monitoring of Intracranial Pressure |
|
|
513 | (2) |
|
Intracranial Pressure Waveforms |
|
|
514 | (1) |
|
Special Procedures: Management of a Patient with a Lumbar Drain |
|
|
515 | (1) |
|
|
|
515 | (2) |
|
|
|
515 | (1) |
|
|
|
515 | (1) |
|
|
|
516 | (1) |
|
|
|
516 | (1) |
|
Intracranial Pressure Monitoring |
|
|
516 | (1) |
|
Evidence-Based Guidelines |
|
|
516 | (1) |
| Section IV. Key Reference Information |
|
517 | (26) |
|
21 Normal Laboratory Reference Values |
|
|
519 | (4) |
|
|
|
|
|
|
|
523 | (12) |
|
|
|
23 Cardiac Rhythms, ECG Characteristics, and Treatment Guide |
|
|
535 | (8) |
|
|
| Index |
|
543 | |
